Prognostic significance of palliative gastrectomy in incurable advanced gastric cancer: a retrospective cohort study and meta-analysis

被引:10
|
作者
Zheng, C. [1 ]
Gao, Z-M [1 ]
Huang, H-B [1 ]
Li, K. [1 ]
Liu, X-F [1 ]
机构
[1] China Med Univ, Dept Surg Oncol & Gen Surg, Affiliated Hosp, Shenyang, Peoples R China
关键词
Gastric cancer; Incurable; Palliative gastrectomy; Metastasis; NON-CURATIVE GASTRECTOMY; PLUS CHEMOTHERAPY; SURVIVAL BENEFIT; RESECTION; SURGERY; MORTALITY; IMPACT; RATES; AGE;
D O I
10.26355/eurrev_202103_25262
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
OBJECTIVE: There is controversy regarding the role of palliative gastrectomy in patients with incurable advanced gastric cancer requiring surgical intervention. The present retrospective cohort study and meta-analysis aimed to determine whether palliative gastrectomy plus chemotherapy can prolong the survival of patients with incurable advanced gastric cancer requiring surgical intervention. PATIENTS AND METHODS: The data from 153 patients diagnosed with incurable advanced gastric cancer requiring surgical intervention at our institute between January 2000 and December 2012 were retrospectively reviewed. We analyzed the value of palliative gastrectomy and identified the potential prognostic factors. We also conducted a meta-analysis of 10 studies to validate our results. RESULTS: Multivariate analysis indicated that palliative gastrectomy was a favorable independent prognostic factor for prolonged overall survival in incurable advanced gastric cancer patients requiring surgical intervention (p=0.029). The median survival of patients who underwent palliative gastrectomy plus chemotherapy was significantly longer than that of those who underwent non-resection surgery plus chemotherapy (12 months vs. 9 months, p=0.020). The patients in the non-resection surgery plus chemotherapy group exhibited significantly shorter overall survival than those in the D1+ lymphadenectomy group, D2 lymphadenectomy group, or distal gastrectomy group (p=0.021, p= 0.007, and p=0.006, respectively). Our meta-analysis revealed that gastrectomy plus chemotherapy improved long-term survival in incurable advanced gastric cancer patients (hazard ratio (HR): 0.48; 95% confidence interval (CI): 0.35-0.67; p<0.001). CONCLUSIONS: Palliative gastrectomy plus chemotherapy may improve overall patient survival compared with non-resection operations plus chemotherapy in incurable advanced gastric cancer patients requiring surgical intervention.
引用
收藏
页码:2299 / 2312
页数:14
相关论文
共 50 条
  • [11] Gastrectomy with or without Complete Omentectomy for Advanced Gastric Cancer: A Meta-Analysis
    Zizzo, Maurizio
    Zanelli, Magda
    Sanguedolce, Francesca
    Palicelli, Andrea
    Ascani, Stefano
    Morini, Andrea
    Tumiati, David
    Mereu, Federica
    Zuliani, Antonia Lavinia
    Nardecchia, Melissa
    Gatto, Francesca
    Zanni, Manuel
    Giunta, Alessandro
    MEDICINA-LITHUANIA, 2022, 58 (09):
  • [12] Prognostic value of the advanced lung cancer inflammation index in patients with gastric cancer after radical gastrectomy: a propensity-score matching cohort study and meta-analysis
    Pang, Huayang
    Dai, Lingyan
    Chen, Lihui
    Chen, Xiufeng
    Chen, Zhixiong
    Zhang, Shouru
    Sun, Hao
    BMC CANCER, 2024, 24 (01)
  • [13] Palliative gastrectomy plus chemotherapy versus chemotherapy alone for incurable advanced gastric cancer: a meta-analysis (Publication with Expression of Concern. See vol. 15, pg. 365, 2023)
    Wu, Pei
    Wang, Pengliang
    Ma, Bin
    Yin, Songcheng
    Tan, Yuen
    Hou, Wenbin
    Wang, Zhenning
    Xu, Huimian
    Zhu, Zhi
    CANCER MANAGEMENT AND RESEARCH, 2018, 10 : 4759 - 4771
  • [14] Is vagotomy necessary in palliative surgery for incurable advanced gastric cancer?: a retrospective case–control study
    Yong-Eun Park
    World Journal of Surgical Oncology, 21
  • [15] Survival benefits of palliative gastrectomy for gastric cancer patients with liver metastasis: a population-based propensity score-matched cohort analysis
    Ren, Bingyi
    Yang, Yichen
    Lv, Yi
    Liu, Kang
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [16] Gastrectomy for Stage IV Gastric Cancer. A Systematic Review and Meta-analysis
    Lasithiotakis, Konstantinos
    Antoniou, Stavros A.
    Antoniou, George A.
    Kaklamanos, Ioannis
    Zoras, Odysseas
    ANTICANCER RESEARCH, 2014, 34 (05) : 2079 - 2085
  • [17] Prognostic significance of osteopontin expression in gastric cancer: a meta-analysis
    Gu, Xiaobin
    Gao, Xian-Shu
    Ma, Mingwei
    Qin, Shangbin
    Qi, Xin
    Li, Xiaoying
    Sun, Shaoqian
    Yu, Hao
    Wang, Wen
    Zhou, Dong
    ONCOTARGET, 2016, 7 (43) : 69666 - 69673
  • [19] Laparoscopic vs open D2 gastrectomy for locally advanced gastric cancer: A meta-analysis
    Zou, Zhen-Hong
    Zhao, Li-Ying
    Mou, Ting-Yu
    Hu, Yan-Feng
    Liu, Jiang Yu Hao
    Chen, Hao
    Wu, Jia-Ming
    An, Sheng-Li
    Li, Guo-Xin
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (44) : 16750 - 16764
  • [20] Clinicopathological and prognostic significance of SPARC expression in gastric cancer: A meta-analysis and bioinformatics analysis
    Sun, Jing
    Bai, Yang-Kai
    Fan, Zhi-Gang
    ONCOLOGY LETTERS, 2023, 25 (06)